Zhuojun Liu
Beijing Key Laboratory Of Cell And Gene Therapy For Hematologic Malignancies
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Ectopic EBV Infection in T Cells Identifies Reduced Therapeutic Responsiveness and Immune Dysfunction After Allogeneic Hematopoietic Stem Cell Transplantation.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: May 19, 2026
Can one scoring system fit all? Comparative validation of CAR-HEMATOTOX, ALL-HEMATOTOX, and eIPM for predicting immune effector cell-associated hematotoxicity following CAR-T therapy in hematologic malignancies.
Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: July 10, 2025
Editorial: Linking cellular metabolism to hematological malignancies, volume II.
Journal: Frontiers in oncology
Published: February 17, 2024
VHL mutation drives human clear cell renal cell carcinoma progression through PI3K/AKT-dependent cholesteryl ester accumulation.
Journal: EBioMedicine
Published: April 20, 2023
Single-Cell Transcriptomics Reveals Immune Reconstitution in Patients with R/R T-ALL/LBL Treated with Donor-Derived CD7 CAR-T Therapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 21, 2022
Reprogramming lipid metabolism as potential strategy for hematological malignancy therapy.
Journal: Frontiers in oncology
Published: July 06, 2022
Ibrutinib Inhibits Angiogenesis and Tumorigenesis in a BTK-Independent Manner.
Journal: Pharmaceutics
Published: June 09, 2022
A colloidal gold-based immunochromatographic strip for rapid detection of SARS-CoV-2 antibodies after vaccination.
Journal: Medicine in novel technology and devices
Published: May 19, 2021
Distinct BTK inhibitors differentially induce apoptosis but similarly suppress chemotaxis and lipid accumulation in mantle cell lymphoma.
Journal: BMC cancer
Published: August 18, 2020
Antibody-Based Immunotherapeutic Strategies for the Treatment of Hematological Malignancies.
Journal: BioMed research international
Published: July 31, 2020
Application of Chimeric Antigen Receptor T Cells in the Treatment of Hematological Malignancies.
Journal: BioMed research international
Published: July 21, 2020
Destabilization of ROR1 enhances activity of Ibrutinib against chronic lymphocytic leukemia in vivo.
Destabilization of ROR1 enhances activity of Ibrutinib against chronic lymphocytic leukemia in vivo.
Journal: Pharmacological research
Published: September 30, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026